Tempest Therapeutics, Inc. (TPST) Income Statement 2013 - 2025

Tempest Therapeutics, Inc.

NasdaqCM:TPST

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

Location

United States

Market Cap

USD 28.58 M

Share Price

USD 7.76

Avg Daily Volume

120,730

Change (1 day)

20.50%

Change (1 year)

Change (YTD)

-27.27%

Tempest Therapeutics, Inc. Income Statement 2015 - 2025

This table shows the Income Statement for Tempest Therapeutics, Inc. going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.